Wave Life Sciences (WVE) Net Income Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 60.43% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -46.86% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 19.97% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 47.10% |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - | 1.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.63% |
| Dec 31, 2025 | -6.76% |
| Sep 30, 2025 | -11.35% |
| Jun 30, 2025 | -6.92% |
| Mar 31, 2025 | -7.43% |
| Dec 31, 2024 | 41.63% |
| Sep 30, 2024 | -114.84% |
| Jun 30, 2024 | 5.30% |
| Mar 31, 2024 | 9.42% |
| Dec 31, 2023 | 17.35% |
| Sep 30, 2023 | 30.43% |
| Jun 30, 2023 | 19.55% |
| Mar 31, 2023 | 16.75% |
| Dec 31, 2022 | 8.35% |
| Sep 30, 2022 | 8.39% |
| Jun 30, 2022 | 0.52% |
| Mar 31, 2022 | 5.07% |
| Dec 31, 2021 | 2.81% |
| Sep 30, 2021 | 45.09% |
| Jun 30, 2021 | -2.60% |
| Mar 31, 2021 | -6.41% |
| Dec 31, 2020 | 1.19% |
| Sep 30, 2020 | -9.09% |
| Jun 30, 2020 | -18.11% |
| Mar 31, 2020 | -31.06% |
| Dec 31, 2019 | -44.76% |
| Sep 30, 2019 | -42.49% |
| Jun 30, 2019 | -53.64% |
| Mar 31, 2019 | -77.93% |
| Dec 31, 2018 | -74.76% |
| Sep 30, 2018 | -96.81% |
| Jun 30, 2018 | -113.28% |
| Mar 31, 2018 | -116.66% |
| Dec 31, 2017 | -157.57% |
| Sep 30, 2017 | -165.45% |